Product Information
LIRAGLUTIDE 3-PAK 18 MG/3 ML is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $33.4153 per ML under NDC 00480366722. Its NADAC has been published 93 times since Sep 18, 2024.
Strength
6 mg/mL
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00480366722
Classification
Generic
Dosage Form
INJECTION
Route
SUBCUTANEOUS
Last Updated
6/17/2026
Active Ingredients
LIRAGLUTIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA022341On Market Since
6/24/2024
Pharmacological Classes
Price Statistics
The NADAC for LIRAGLUTIDE 3-PAK 18 MG/3 ML has been published 93 times since Sep 18, 2024, and over the history we have for it it has declined 54.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $33.4153 per ML |
|---|---|
| All-time high | $72.9945 (Dec 11, 2024) |
| All-time low | $33.4153 (Jun 17, 2026) |
| 52-week high | $57.5349 |
| 52-week low | $33.4153 |
| Median price | $55.5874 |
| Average price | $56.9891 |
| Largest weekly change | -10.6% (Feb 18, 2026) |
| Weeks tracked | 93 |
| Tracking since | Sep 18, 2024 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LIRAGLUTIDE 3-PAK 18 MG/3 ML?
The current National Average Drug Acquisition Cost (NADAC) for LIRAGLUTIDE 3-PAK 18 MG/3 ML, manufactured by Teva Pharmaceuticals USA Inc., is $33.4153 per ML (NDC 00480366722), effective Jun 24, 2026.
How has the price of LIRAGLUTIDE 3-PAK 18 MG/3 ML changed over time?
Over the history we have for it, the NADAC for LIRAGLUTIDE 3-PAK 18 MG/3 ML has declined 54.2%. It has been tracked across 93 weekly CMS publications since Sep 18, 2024.
What are the highest and lowest recorded NADAC prices for LIRAGLUTIDE 3-PAK 18 MG/3 ML?
Since Sep 18, 2024, the NADAC for LIRAGLUTIDE 3-PAK 18 MG/3 ML has ranged from a low of $33.4153 (Jun 17, 2026) to a high of $72.9945 (Dec 11, 2024), with a median of $55.5874 per ML.
Are there cheaper alternatives to LIRAGLUTIDE 3-PAK 18 MG/3 ML?
4 NADAC-published products share the same active ingredient, strength, and dosage form as LIRAGLUTIDE 3-PAK 18 MG/3 ML, but none are currently priced below it.
Who manufactures LIRAGLUTIDE 3-PAK 18 MG/3 ML?
LIRAGLUTIDE 3-PAK 18 MG/3 ML (NDC 00480366722) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification